Cancer News and Research

Latest Cancer News and Research

Statin therapy prevents cancer and reduces death risk in heart transplant recipients

Statins prevent cancer and reduce death from all causes in heart transplant recipients. The findings were independent of cholesterol levels.

21 May 2012

Review examines benefits and harms of LDCT screening for lung cancer

Peter B. Bach, M.D., of the Memorial Sloan-Kettering Cancer Center, New York, and colleagues conducted a systematic review to examine the evidence regarding the benefits and harms of low-dose computerized tomography (LDCT) screening for lung cancer, which is the leading cause of cancer death. "Most patients are diagnosed with advanced disease, resulting in a very low 5-year survival rate," the authors write.

21 May 2012

Study uncovers distinct subtype of prostate cancer

A collaborative expedition into the deep genetics of prostate cancer has uncovered a distinct subtype of the disease, one that appears to account for up to 15 percent of all cases, say researchers at Weill Cornell Medical College, the Broad Institute of MIT and Harvard and the Dana-Farber Cancer Institute.

21 May 2012

Study identifies biomarkers that predict patients' response to certain colon cancer drugs

The Stem Cells and Cancer Research Group headed by Dr H-ctor G. Palmer at the Vall d'Hebr-n Institute of Oncology (VHIO) has identified the molecular mechanisms that determine patients' response to certain drugs used in clinical trials for colon cancer treatment. The study led by VHIO also benefited from the collaboration with Professor Alberto Mu-oz-s laboratory at the Instituto de Investigaciones Biomedicas Alberto Sols, Consejo Superior de Investigaciones Cient-ficas.

21 May 2012

Panobinostat able to target and destroy triple negative breast cancer

The histone de-acetylase (HDAC) inhibitor panobinostat is able to target and destroy triple negative breast cancer, reveals a new study published in BioMed Central's open access journal Breast Cancer Research.

21 May 2012

Study uncovers mechanism by which Notch pathway could contribute to RA

A new study led by researchers at Hospital for Special Surgery identifies the mechanism by which a cell signaling pathway contributes to the development of rheumatoid arthritis (RA). In addition, the study provides evidence that drugs under development for diseases such as cancer could potentially be used to treat RA.

21 May 2012

Online instructional video improves patient compliance with colonoscopy

Patients who watch an online instructional video are more likely to keep their appointments and arrive prepared for a scheduled colonoscopy than those who do not, according to a study by gastroenterologists at the University of Chicago Medicine.

21 May 2012

Sleep-disordered breathing may increase risk of cancer mortality

Sleep-disordered breathing (SDB), commonly known as sleep apnea, is associated with an increased risk of cancer mortality, according to a new study.

21 May 2012

LKCF, Spirit of Women’s HeartCaring to help reduce disparities in diagnosis and care

In an ongoing effort to save the lives of thousands of Americans at risk of cardiovascular ailments each year, Spirit of Women Health Network has joined forces with the Larry King Cardiac Foundation (LKCF) to help reduce the devastating disparity in the diagnostics, clinical care, and survival rate of heart attacks, strokes and other heart events for women and people of color.

19 May 2012

Certain types of fat associated with worse memory and overall cognitive function

It has been known for years that eating too many foods containing "bad" fats, such as saturated fats or trans fats, isn't healthy for your heart. However, according to new research from Brigham and Women's Hospital (BWH), one "bad" fat-saturated fat-was found to be associated with worse overall cognitive function and memory in women over time. By contrast, a "good" fat-mono-unsaturated fat was associated with better overall cognitive function and memory.

19 May 2012

Palliative care interventions may boost overall survival of cancer patients

Recent studies have shown that palliative care interventions aimed at addressing patients' emotional, spiritual and social needs have a significant impact on cancer patients' quality of life and may even improve cancer patients' overall survival. Despite this, most cancer patients being cared for in their communities do not have access to these services.

19 May 2012

Crownsville student receives Gordon E. Moore Award for pancreatic cancer test

Jack Andraka, 15, of Crownsville, Md. was awarded first place for his new method to detect pancreatic cancer at this year's Intel International Science and Engineering Fair, a program of Society for Science & the Public. Based on diabetic test paper, Jack created a simple dip-stick sensor to test blood or urine to determine whether or not a patient has early-stage pancreatic cancer.

19 May 2012

Urologic conditions contribute to major economic burden in the U.S.

Urologic conditions like urinary tract infections, kidney stones, and prostate cancer are a major economic burden on Americans, resulting in health care costs of close to $40 billion annually, according to a newly released national report that charts the demographic and economic impact of urologic diseases in the U.S.

19 May 2012

Viewpoints: VA failing to provide timely care; Roll up your sleeves to help fight AIDS; Primary care doctors' uncertain future

Those who have served know the military rules: Be on time, do it now. Once they file disability claims with the Department of Veteran Affairs, however, veterans wait, and wait longer…. Delay is not without consequences for the individual or the community…. We sent these young men and women off to battle. We owe them timely care.

19 May 2012

Biovest announces new data from BiovaxID Phase II mantle cell lymphoma trial

Biovest International, Inc., a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc., today announced that an abstract reporting new data from the BiovaxID Phase II mantle cell lymphoma clinical trial conducted by the U.S. National Cancer Institute (NCI) is now available on-line with the significance of these results to be presented by the NCI at the 2012 American Society of Clinical Oncology Annual Meeting.

19 May 2012

Studies show vitamin D may benefit cardiovascular, skin and metabolic disorders

The Endocrine Society's new scientific statement published online today represents the first comprehensive evaluation of both the basic and clinical evidence related to the non-skeletal effects of vitamin D. The statement addresses current research regarding the associations of vitamin D with immune function, hypertension, stroke, skin conditions and maternal/fetal health.

19 May 2012

APS honors recipients of Clinical Centers of Excellence in Pain Management Awards

The American Pain Society (APS), honored the recipients of its sixth annual Clinical Centers of Excellence in Pain Management Awards recognizing the nation's outstanding pain care centers.

19 May 2012

Daiichi Sankyo, ArQule complete enrollment in tivantinib plus erlotinib Phase 3 NSCLC trial

ArQule, Inc. and Daiichi Sankyo, Co., Ltd. today announced that recruitment of patients has been completed in the randomized, double-blind, controlled Phase 3 MARQUEE pivotal trial of their investigational selective c-MET inhibitor, tivantinib, in combination with erlotinib in previously treated patients with locally advanced or metastatic, non-squamous, non-small cell lung cancer.

19 May 2012

Personal genetic test results does not drive overuse of expensive medical care

People have increasing opportunities to participate in genetic testing that can indicate their range of risk for developing a disease. Receiving these results does not appreciably drive up or diminish test recipients' demand for potentially costly follow-up health services, according to a study performed by researchers at the National Institutes of Health and colleagues at other institutions.

19 May 2012

Mount Sinai cancer researchers to present several landmark studies at ASCO meeting

Mount Sinai School of Medicine researchers will present several landmark studies, including data on treatment trends in late-stage cancer, a promising multiple myeloma vaccine, and predictive models of soft tissue sarcomas, prostate and bladder cancer, at the 2012 American Society of Clinical Oncology (ASCO) meeting June 1-5, 2012 in Chicago.

19 May 2012

Cancer News and Research

Latest Cancer News and Research

Statin therapy prevents cancer and reduces death risk in heart transplant recipients

Review examines benefits and harms of LDCT screening for lung cancer

Study uncovers distinct subtype of prostate cancer

Study identifies biomarkers that predict patients' response to certain colon cancer drugs

Panobinostat able to target and destroy triple negative breast cancer

Study uncovers mechanism by which Notch pathway could contribute to RA

Online instructional video improves patient compliance with colonoscopy

Sleep-disordered breathing may increase risk of cancer mortality

LKCF, Spirit of Women’s HeartCaring to help reduce disparities in diagnosis and care

Certain types of fat associated with worse memory and overall cognitive function

Palliative care interventions may boost overall survival of cancer patients

Crownsville student receives Gordon E. Moore Award for pancreatic cancer test

Urologic conditions contribute to major economic burden in the U.S.

Viewpoints: VA failing to provide timely care; Roll up your sleeves to help fight AIDS; Primary care doctors' uncertain future

Biovest announces new data from BiovaxID Phase II mantle cell lymphoma trial

Studies show vitamin D may benefit cardiovascular, skin and metabolic disorders

APS honors recipients of Clinical Centers of Excellence in Pain Management Awards

Daiichi Sankyo, ArQule complete enrollment in tivantinib plus erlotinib Phase 3 NSCLC trial

Personal genetic test results does not drive overuse of expensive medical care

Mount Sinai cancer researchers to present several landmark studies at ASCO meeting

Cancer Research - Second Edition eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in